Berberine: Glucose Evidence, Formulations and Safety
Berberine studies suggest short-term glucose and lipid-marker changes, but do not establish a prescription-drug substitute. Formulation, funding, trial quality and medication interactions matter.
Evidence-graded research on diabetes and blood-sugar control — what the systematic reviews and trials really show about diet, supplements and metabolic health.
Berberine studies suggest short-term glucose and lipid-marker changes, but do not establish a prescription-drug substitute. Formulation, funding, trial quality and medication interactions matter.
Review selected diabetes supplements, with glucose-marker findings, trial limitations, source funding and medicine-specific safety precautions.
Key takeaways A Cochrane review of 12 RCTs (5,238 participants) found combined diet plus physical activity cut type 2 diabetes incidence with a risk ratio of 0.57 versus standard care — about a 43% reduction in high-risk adults. The Diabetes Prevention Program showed intensive lifestyle change (targeting 7% weight loss and 150 min/week of activity) … Read more
Vitamin D supports bone and mineral health. D3 generally raises blood levels more than D2; disease-prevention benefits depend on the population. Compare forms, dosing guidance, interactions and funding limitations.
Key takeaways Strongest evidence: modest triglyceride reduction (around 20–30% with 4 g/day prescription omega-3 in people with elevated triglycerides) and reduced cardiovascular events in secondary prevention at prescription doses — FDA has approved icosapent ethyl (EPA-only, 4 g) after the REDUCE-IT trial. (Primary source) For primary prevention of heart disease in the general population, effects … Read more
Get the topics, key findings and links from our new articles in one email. At most one digest a day, only when there is something new.